Thomas Cochin
Research Subjects
Thomas Cochin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Coutte
CHU, Amiens, France
1 shared publication - Audrey Larnaudie
Centre François Baclesse, Caen, France
1 shared publication - Audrey Rambeau
Medical Oncology Department, Centre Francois Baclesse, Caen, France
1 shared publication - Emmanuel Kammerer
Centre François Baclesse, Caen
1 shared publication - Jacques Balosso
Department of Radiation Oncology, Centre Francois Baclesse, 14000 Caen, France
1 shared publication - Jennifer Le Guevelou
Department of Radiation Oncology CHRU Tours Tours France
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study
ObjectiveRadiotherapy for nasopharyngeal cancers is associated with frequent digestive and nutritional toxicities, weight loss (WL), and malnutrition, criteria of poor tolerance and poor prognosis. The primary objective of DRAKAR is to evaluate of benefit of anticipated EN during radiotherapy for nasopharyngeal cancer, in a non-endemically affected French population.Materials and methodsDRAKAR is a retrospective, multicenter study conducted in five French centers. Patients received radiotherapy with curative intent, with or without concurrent chemotherapy, for primary nasopharyngeal cancer between 2015 and 2024. The primary endpoint was WL according to nutritional support modality at the end of radiotherapy. Secondary endpoints included rates of moderate and severe malnutrition (5% or 10% WL in one month for moderate and severe malnutrition), grade ≥ 3 toxicities, dosimetric parameters (volumes, particles), use and duration of enteral nutrition and parenteral nutrition, prolonged radiotherapy due to treatment interruption, hospitalizations, and overall survival.ResultsA total of 124 patients were analyzed (59.7% UCNT, 40.3% squamous cell carcinoma). At one month, 35.5% presented with malnutrition. Mean WL was 7.46% at the end of radiotherapy and 9.11% at three months. Enteral nutrition was used in 55.6% of patients, including 16.1% prophylactically. Prophylactic enteral nutrition allowed stabilization of WL after treatment. Grade ≥ 3 mucositis and radiation-induced nausea and vomiting occurred in 31.5% and 14.5% of patients, respectively. No association was found between toxicities and clinical, dosimetric, or therapeutic characteristics.ConclusionIn patients treated for nasopharyngeal cancer, prophylactic enteral nutrition was associated with lower WL at the end of radiotherapy. Although it had neither positive impact on hospitalization rates nor on overall survival, these results support prophylactic nutritional support during radiotherapy of nasopharyngeal cancers, mainly for post-treatment WL.
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study
ObjectiveRadiotherapy for nasopharyngeal cancers is associated with frequent digestive and nutritional toxicities, weight loss (WL), and malnutrition, criteria of poor tolerance and poor prognosis. The primary objective of DRAKAR is to evaluate of benefit of anticipated EN during radiotherapy for nasopharyngeal cancer, in a non-endemically affected French population.Materials and methodsDRAKAR is a retrospective, multicenter study conducted in five French centers. Patients received radiotherapy with curative intent, with or without concurrent chemotherapy, for primary nasopharyngeal cancer between 2015 and 2024. The primary endpoint was WL according to nutritional support modality at the end of radiotherapy. Secondary endpoints included rates of moderate and severe malnutrition (5% or 10% WL in one month for moderate and severe malnutrition), grade ≥ 3 toxicities, dosimetric parameters (volumes, particles), use and duration of enteral nutrition and parenteral nutrition, prolonged radiotherapy due to treatment interruption, hospitalizations, and overall survival.ResultsA total of 124 patients were analyzed (59.7% UCNT, 40.3% squamous cell carcinoma). At one month, 35.5% presented with malnutrition. Mean WL was 7.46% at the end of radiotherapy and 9.11% at three months. Enteral nutrition was used in 55.6% of patients, including 16.1% prophylactically. Prophylactic enteral nutrition allowed stabilization of WL after treatment. Grade ≥ 3 mucositis and radiation-induced nausea and vomiting occurred in 31.5% and 14.5% of patients, respectively. No association was found between toxicities and clinical, dosimetric, or therapeutic characteristics.ConclusionIn patients treated for nasopharyngeal cancer, prophylactic enteral nutrition was associated with lower WL at the end of radiotherapy. Although it had neither positive impact on hospitalization rates nor on overall survival, these results support prophylactic nutritional support during radiotherapy of nasopharyngeal cancers, mainly for post-treatment WL.